A Bayesian meta-analysis of prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in children with cancer.
暂无分享,去创建一个
J Hayden | G A Tomlinson | P. Nathan | G. Tomlinson | J. Beyene | J. Hayden | L. Sung | J Beyene | L Sung | P C Nathan | B Lange | B. Lange | G. Tomlinson
[1] A. Baruchel,et al. Use of recombinant human granulocyte colony-stimulating factor to increase chemotherapy dose-intensity: a randomized trial in very high-risk childhood acute lymphoblastic leukemia. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] M. Relling,et al. Human granulocyte colony-stimulating factor after induction chemotherapy in children with acute lymphoblastic leukemia. , 1997, The New England journal of medicine.
[3] Jill Hayden,et al. Seven items were identified for inclusion when reporting a Bayesian analysis of a clinical study. , 2005, Journal of clinical epidemiology.
[4] A. D. de Craen,et al. Granulocyte-macrophage colony-stimulating factor (GM-CSF) ameliorates chemotherapy-induced neutropenia in children with solid tumors. , 1997, Pediatric hematology and oncology.
[5] M. Schrappe,et al. A randomized phase-III study of the efficacy of granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia. Berlin-Frankfurt-Münster Study Group. , 1996, Blood.
[6] J. Shuster,et al. Randomized trial of r-metHu granulocyte colony-stimulating factor in an intensive treatment for T-cell leukemia and advanced-stage lymphoblastic lymphoma of childhood: a Pediatric Oncology Group pilot study. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] Mark L. Greenberg,et al. Concurrent RhGM‐CSF does not offset myelosuppression from intensive chemotherapy: Randomized placebo‐controlled study in childhood acute lymphoblastic leukemia , 1994, American journal of hematology/oncology.
[8] S. Burdach,et al. Granulocyte‐macrophage‐colony stimulating factor for prevention of neutropenia and infections in children and adolescents with solid tumors. Results of a prospective randomized study , 1995, Cancer.
[9] E. Bouffet,et al. An open-label, multicentre, randomised phase 2 study of recombinant human granulocyte colony-stimulating factor (filgrastim) as an adjunct to combination chemotherapy in paediatric patients with metastatic neuroblastoma. , 1998, European journal of cancer.
[10] F. Dunstan,et al. Granulocyte colony-stimulating factor ameliorates toxicity of intensification chemotherapy for acute lymphoblastic leukemia. , 1999, Medical and pediatric oncology.
[11] C. R. Pinkerton,et al. A randomised study of prophylactic G-CSF following MRC UKALL XI intensification regimen in childhood ALL and T-NHL. , 2002, Medical and pediatric oncology.
[12] S. Steinberg,et al. Randomized trial of recombinant human granulocyte-macrophage colony-stimulating factor in pediatric patients receiving intensive myelosuppressive chemotherapy. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] Two cheers for Bayes. , 1996, Controlled clinical trials.
[14] K. Welte,et al. HAEMATOPOIETIC GROWTH FACTORS IN CHILDREN WITH NEUTROPENIA , 2002, British journal of haematology.
[15] A. Berger. FUNDAMENTALS OF BIOSTATISTICS , 1969 .
[16] B. Bloom,et al. Classic or Bayesian research design and analysis. Does it make a difference? , 2002, International journal of technology assessment in health care.
[17] P. Riikonen,et al. Prophylactic administration of granulocyte colony‐stimulating factor (filgrastim) after conventional chemotherapy in children with cancer , 1995, Stem cells.
[18] A. Baruchel,et al. Granulocyte colony-stimulating factor in induction treatment of children with non-Hodgkin's lymphoma: a randomized study of the French Society of Pediatric Oncology. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] P. Nathan,et al. Prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor decrease febrile neutropenia after chemotherapy in children with cancer: a meta-analysis of randomized controlled trials. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] S. Jhanwar,et al. Human Granulocyte Colony-Stimulating Factor in Children With High-Risk Acute Lymphoblastic Leukemia: A Children’s Cancer Group Study , 2003 .
[21] R. Ragusa,et al. Assessment of the value of treatment with granulocyte colony‐stimulating factor in children with acute lymphoblastic leukemia: a randomized clinical trial , 1995, European journal of haematology.
[22] Gareth O. Roberts,et al. Convergence assessment techniques for Markov chain Monte Carlo , 1998, Stat. Comput..